The Lakebase service has been in development since June 2025 and is based on technology Databricks gained via its acquisition ...
The chief development officer of Corcept Therapeutics sold 20,000 shares of the biotech for $703,656 on Tuesday. The transaction was executed as a direct open-market sale of option shares; no indirect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results